Diagnosis and treatment of neonatal seizures is challenging, not least since a majority of seizures are subclinical and there is a lack of randomised studies investigating antiepileptic medications. Newborn infants with seizures have a high risk for adverse outcomes. However, a more effective management may lead to improved outcomes in the future.
As a part of the EU FP7 funded project NEMO (Treatment of NEonatal seizures with Medication Off-patent), we are now conducting a European survey on management (including diagnosis and treatment) of neonatal seizures.
The survey consists of background section of short questions, asking about the specialty of the responder, the type of hospital and the country the responder is working in. The background section is followed by three clinical scenarios (birth asphyxia, meconium aspiration, very preterm infant) with questions about diagnosis and treatment of infants in these scenarios.
The survey takes around 5-10 minutes. The survey is anonymous, but those who provide their e-mail will get a summary of the survey.